PROTHENA CORPORATION PUBLIC LIMITED COMPANY
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.7M | $135.2M | $91.4M | $53.9M | $200.6M | $853.0K | $814.0K | $955.0K |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | $134.9M | $222.5M | $220.6M | $135.6M | $82.3M | $74.9M | $50.8M | $101.2M |
| SG&A Expense | $59.4M | $67.2M | $61.8M | $49.9M | $46.3M | $38.7M | $35.7M | $42.5M |
| Operating Income | $-214.6M | $-154.6M | $-191.0M | $-131.6M | $72.0M | $-112.7M | $-85.7M | $-158.9M |
| Operating Margin | -2,216.4% | -114.4% | -209.1% | -244.1% | 35.9% | -13,216.2% | -10,527.9% | -16,634.0% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $-200.8M | $-128.9M | $-160.5M | $-125.6M | $71.9M | $-111.4M | $-77.3M | $-156.1M |
| Income Tax Expense | $43.3M | $-6.6M | $-13.5M | $-8.7M | $4.9M | $-283.0K | $379.0K | $-470.0K |
| Net Income | $-244.1M | $-122.3M | $-147.0M | $-116.9M | $67.0M | $-111.1M | $-77.7M | $-155.6M |
| Net Margin | -2,520.6% | -90.5% | -160.9% | -217.0% | 33.4% | -13,029.8% | -9,542.6% | -16,297.9% |
| EPS (Basic) | $-4.53 | $-2.27 | $-2.76 | $-2.47 | $1.51 | $-2.78 | $-1.95 | $-3.93 |
| EPS (Diluted) | $-4.53 | $-2.27 | $-2.76 | $-2.47 | $1.38 | $-2.78 | $-1.95 | $-3.93 |
| Shares Outstanding (Basic) | 53.8M | 53.8M | 53.2M | 47.4M | 44.2M | 39.9M | 39.9M | 39.9M |
| Shares Outstanding (Diluted) | 53.8M | 53.8M | 53.2M | 47.4M | 48.5M | 39.9M | 39.9M | 39.9M |
| Dividends Per Share | — | — | — | — | — | — | — | — |